医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2015年
14期
280-280
,共1页
青光眼%视神经萎缩%中西医结合
青光眼%視神經萎縮%中西醫結閤
청광안%시신경위축%중서의결합
Glaucoma%Optic atrophy%Combination of TCM and Western Medicine
目的研究并讨论青光眼视神经萎缩的临床治疗。方法选自我院80例青光眼视神经萎缩患者,随机分为两组,对照组40例患者接受常规西医治疗,而研究组40例患者在常规治疗基础上给予中医组方治疗,对患者进行临床疗效分析。结果研究组的总有效率为95.0%;显著高于对照组的总有效率为72.5%,有统计学意义(P<0.05);治疗前,两组患者的视野光敏度、视野缺损、眼底c/d水平差异无统计学意义(>0.05);治疗后,研究组的视野光敏度、视野缺损、眼底c/d水平差异显著,有统计学意义(P<0.05)。结论中西医结合疗效是显著的,这种方法使得患者的治疗更为安全,具有临床推广价值。
目的研究併討論青光眼視神經萎縮的臨床治療。方法選自我院80例青光眼視神經萎縮患者,隨機分為兩組,對照組40例患者接受常規西醫治療,而研究組40例患者在常規治療基礎上給予中醫組方治療,對患者進行臨床療效分析。結果研究組的總有效率為95.0%;顯著高于對照組的總有效率為72.5%,有統計學意義(P<0.05);治療前,兩組患者的視野光敏度、視野缺損、眼底c/d水平差異無統計學意義(>0.05);治療後,研究組的視野光敏度、視野缺損、眼底c/d水平差異顯著,有統計學意義(P<0.05)。結論中西醫結閤療效是顯著的,這種方法使得患者的治療更為安全,具有臨床推廣價值。
목적연구병토론청광안시신경위축적림상치료。방법선자아원80례청광안시신경위축환자,수궤분위량조,대조조40례환자접수상규서의치료,이연구조40례환자재상규치료기출상급여중의조방치료,대환자진행림상료효분석。결과연구조적총유효솔위95.0%;현저고우대조조적총유효솔위72.5%,유통계학의의(P<0.05);치료전,량조환자적시야광민도、시야결손、안저c/d수평차이무통계학의의(>0.05);치료후,연구조적시야광민도、시야결손、안저c/d수평차이현저,유통계학의의(P<0.05)。결론중서의결합료효시현저적,저충방법사득환자적치료경위안전,구유림상추엄개치。
Objective To study and discuss the clinical treatment of glaucoma optic atrophy.Methods Selected from our hospital 80 cases of glaucoma optic atrophy patients, randomly divided into two groups, 40 patients in the control group received conventional western medicine treatment, while the study group 40 patients were given TCM prescription therapy on the basis of conventional therapy, the clinical curative ef ect analysis of patients. Results The study group the total ef iciency of 95%;control group, the total ef iciency is substantial y higher than 72.5%, with statistical significance ( <0.05);before the treatment, no statistical significance in the two groups of patients vision photosensitivity, visual field defect, fundus c/d level dif erence ( >0.05);after the treatment, the study group vision photosensitive degree, visual field defect, fundus c/d level significantly, with statistical significance ( < 0.05).Conclusion Combine traditional Chinese and Western medicine curative ef ect is remarkable, this method makes the patient's treatment is more safe, clinical value.